Jeil Pharma Holdings Inc
KRX:002620
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jeil Pharma Holdings Inc
KRX:002620
|
KR |
|
Aston Martin Lagonda Global Holdings PLC
LSE:AML
|
UK |
|
Ling Yun Industrial Corp Ltd
SSE:600480
|
CN |
|
M
|
Max Power Mining Corp
CNSX:MAXX
|
CA |
Intrinsic Value
Is Jeil Pharma Holdings Inc undervalued or overvalued?
See the intrinsic value estimate for Jeil Pharma Holdings Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Jeil Pharma Does
Jeil Pharma Holdings is the parent company of a South Korean pharmaceutical group. Through its operating subsidiaries, it makes and sells prescription medicines, over-the-counter drugs, and related healthcare products used by hospitals, clinics, pharmacies, and consumers. Its business is built around research, development, manufacturing, and sales in the drug market, rather than retailing or consumer branding on its own.
- Headquarters
- Korea KR
- IPO date
- Jan 20, 1988
Revenue & Expenses Breakdown
Jeil Pharma Holdings Inc
Earnings Waterfall
Jeil Pharma Holdings Inc
The intrinsic value for Jeil Pharma Holdings Inc (002620) under the Base Case is hidden KRW.
Compared with the current market price of 6 850 KRW, the stock appears hidden.